Patent · US Active

Method for detecting the risk of alzheimer's disease by detecting immunomagnetic reduction signals of biological markers

US9034582B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 7, 2014
Grant dateMay 19, 2015
Priority date
Expiry dateMar 7, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16H20/70
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method for detecting the risk of Alzheimer's disease comprises detecting immunomagnetic reduction signals of two biological markers in a biological sample from a subject, wherein the two biological markers are tau protein and Aβ-42 protein; and calculating concentrations of the above two biological markers and using the product of the concentrations of the above two biological markers to diagnose the risk of Alzheimer's disease, wherein the concentration is calculated by the conversion of the magnetic reduction signals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.